A significant advance in cancer study is emerging with the use of mini-antibodies to reactivate mutated p53. This essential cancer suppressor protein is frequently disabled in several types of cancer, leading https://businessbookmark.com/story7562079/nanobodies-reactivate-tumor-suppressor-p53-new-promising-pathway-for-malignant-management